News

Molecular Analysis and Testing of New Treatments for Diffuse Midline Gliomas

Molecular Analysis and Testing of New Treatments for Diffuse Midline Gliomas

Molecular Analysis and Testing of New Treatments for Diffuse Midline Gliomas

Diffuse Midline Gliomas in Children Pediatric brain tumors are the leading cause of cancer-related mortality in children. Diffuse midline gliomas are the most common and severe form of malignant gliomas in children and adolescents (between 50 and 100 new cases are expected each year in France). Most affected children die within two years of diagnosis. […]
Find out more

SACHA: the program that secures access to medicines outside clinical trials

SACHA: the program that secures access to medicines outside clinical trials

SACHA: the program that secures access to medicines outside clinical trials

Context of the SACHA Study France stands as a pioneer in Europe in the field of developing new drugs in pediatric oncology. For example, from 2015 to 2018, over 2,200 patients were enrolled in 34 clinical trials by ITCC (Innovative Therapies for Children with Cancer). Among them, 53% of the patients were recruited in France. […]
Find out more